Meridian Bioscience Income Statement
- Quarterly: March 2013 - December 2010 Previous Quarters
- Annual
| Income | 2013-03 | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 |
| Revenue | 47.27M | 45.35M | 43.69M | 42.14M | 47.44M | 40.08M | 41.35M | 40.05M | 41.06M | 37.26M |
| Cost of Goods Sold | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 30.74M | 28.80M | 27.75M | 27.64M | 29.75M | 24.54M | 24.49M | 25.35M | 25.96M | 23.50M |
| Depreciation Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Depreciation, Amortization, Depletion Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| R&D Expense | 2.811M | 2.517M | 2.834M | 2.660M | 2.508M | 2.273M | 2.494M | 2.693M | 2.326M | 2.309M |
| G&A Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| SG&A Expense | 12.68M | 13.19M | 12.87M | 12.37M | 12.41M | 12.46M | 12.14M | 12.53M | 12.67M | 12.10M |
| Total Operating Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non Operating Interest Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Non-Operating Int Exp | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Special Income and Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Income and Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pre-Tax Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Income from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Income | 10.25M | 8.474M | 8.573M | 8.594M | 9.626M | 6.578M | 6.710M | 6.836M | 7.260M | 6.025M |
| Basic EPS | 2013-03 | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 |
| EPS Basic from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Basic | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Diluted EPS | 2013-03 | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 |
| EPS Diluted from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Diluted | 0.2400 | 0.2000 | 0.2060 | 0.2100 | 0.2300 | 0.1600 | 0.1622 | 0.1700 | 0.1800 | 0.1500 |
| Shares Data | 2013-03 | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 |
| Average Basic Shrs Outs | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Diluted Shrs Outs | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividend Per Share | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
